109 related articles for article (PubMed ID: 15499989)
61. Localisation of basic fibroblast growth factor in cholesteatoma matrix: an immunochemical study.
Hamed MA; Sayed RH; Shiogama K; Eltaher MA; Suzuki K; Nakata S
J Laryngol Otol; 2019 Mar; 133(3):183-186. PubMed ID: 30808433
[TBL] [Abstract][Full Text] [Related]
62. [Expression and significance of PDK1 and NF-κB in the middle ear cholesteatoma].
Du L; Xie YD; Liu M
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 May; 30(10):770-773. PubMed ID: 29798050
[No Abstract] [Full Text] [Related]
63. Cell proliferation and apoptosis in human middle ear cholesteatoma.
Kojima H; Tanaka Y; Tanaka T; Miyazaki H; Shiwa M; Kamide Y; Moriyama H
Arch Otolaryngol Head Neck Surg; 1998 Mar; 124(3):261-4. PubMed ID: 9525508
[TBL] [Abstract][Full Text] [Related]
64. Expression of Apoptotic vs Antiapoptotic Proteins in Middle Ear Cholesteatoma.
Chung JH; Lee SH; Park CW; Kim KR; Tae K; Kang SH; Oh YH; Pyo JY
Otolaryngol Head Neck Surg; 2015 Dec; 153(6):1024-30. PubMed ID: 26124267
[TBL] [Abstract][Full Text] [Related]
65. Mediation of signal transduction in keratinocytes of human middle ear cholesteatoma by ras protein.
Huang CC; Chen CT; Huang TS; Shinoda H
Eur Arch Otorhinolaryngol; 1996; 253(7):385-9. PubMed ID: 8891480
[TBL] [Abstract][Full Text] [Related]
66. Expression of disintegrin and metalloproteinase family proteins 10, 12 and 17 in cholesteatoma.
Erbek S; Erinanc H; Hizal E; Ozluoglu LN
J Laryngol Otol; 2013 Feb; 127(2):153-8. PubMed ID: 23318052
[TBL] [Abstract][Full Text] [Related]
67. 44-plex cytokine profile of cholesteatoma.
Britze A; Palmfeldt J; Gregersen N; Ovesen T
Acta Otolaryngol; 2014 Jan; 134(1):41-50. PubMed ID: 24256045
[TBL] [Abstract][Full Text] [Related]
68. Galectin-1, -3, -7 expressions in congenital and acquired pediatric cholesteatomas compared to external auditory canal skin.
Vander Ghinst M; Remmelink M; Mansbach AL; Hassid S; Choufani G
Clin Exp Otorhinolaryngol; 2012 Jun; 5(2):62-7. PubMed ID: 22737285
[TBL] [Abstract][Full Text] [Related]
69. Quantitative analysis of interleukin-1-alpha gene expression in middle ear cholesteatoma.
Bujía J; Kim C; Boyle D; Hammer C; Firestein G; Kastenbauer E
Laryngoscope; 1996 Feb; 106(2 Pt 1):217-20. PubMed ID: 8583857
[TBL] [Abstract][Full Text] [Related]
70. Animal model for cholesteatoma induced in the gerbil: will the profiles of differentiation/growth-regulatory markers be similar to the clinical situation?
Choufani G; Roper N; Delbrouck C; Hassid S; Gabius HJ
Laryngoscope; 2007 Apr; 117(4):706-11. PubMed ID: 17415142
[TBL] [Abstract][Full Text] [Related]
71. Increased expression of Dec-205, Bcl-10, Tim-3, and Trem-1 mRNA in chronic otitis media with cholesteatoma.
Kim MG; Park DC; Oh IH; Kim YI; Choi SA; Jung SY; Kang HM; Yeo SG
Acta Otolaryngol; 2014 May; 134(5):475-80. PubMed ID: 24702227
[TBL] [Abstract][Full Text] [Related]
72. Expression of annexin II in human middle ear cholesteatoma.
Kim TT; Chen CT; Huang CC
Otolaryngol Head Neck Surg; 1998 Mar; 118(3 Pt 1):324-8. PubMed ID: 9527111
[TBL] [Abstract][Full Text] [Related]
73. [The research progress of keratin's roles in the pathology of middle ear cholesteatoma].
Feng YS; Si Y; Zhang ZG
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Nov; 54(11):870-874. PubMed ID: 31795552
[TBL] [Abstract][Full Text] [Related]
74. Upregulation of phosphorylated HSP27, PRDX2, GRP75, GRP78 and GRP94 in acquired middle ear cholesteatoma growth.
Ho KY; Yeh TS; Huang HH; Hung KF; Chai CY; Chen WT; Tsai SM; Chang NC; Chien CY; Wang HM; Wu YJ
Int J Mol Sci; 2013 Jul; 14(7):14439-59. PubMed ID: 23852020
[TBL] [Abstract][Full Text] [Related]
75. Evaluation of YAP signaling in a rat tympanic membrane under a continuous negative pressure load and in human middle ear cholesteatoma.
Akiyama N; Yamamoto-Fukuda T; Yoshikawa M; Kojima H
Acta Otolaryngol; 2017 Nov; 137(11):1158-1165. PubMed ID: 28708445
[TBL] [Abstract][Full Text] [Related]
76. [Expression of PTKs CDK4 and p15 in the middle ear cholesteatomatous epithelium].
Sun W; Xu Z; Tang A; Su J
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2004 Oct; 18(10):616-9. PubMed ID: 15620145
[TBL] [Abstract][Full Text] [Related]
77. Up-regulation of matrix metalloprotease-9 in middle ear cholesteatoma--correlations with growth factor expression in vivo?
Schmidt M; Grünsfelder P; Hoppe F
Eur Arch Otorhinolaryngol; 2001 Nov; 258(9):472-6. PubMed ID: 11769995
[TBL] [Abstract][Full Text] [Related]
78. TNF-R2 expression in acquired middle ear cholesteatoma.
Vitale RF; Pereira CSB; Alves AL; Fregnani JHTG; Ribeiro FQ
Braz J Otorhinolaryngol; 2011; 77(4):531-536. PubMed ID: 21860983
[TBL] [Abstract][Full Text] [Related]
79. Expression of Ras-related C3 botulinum toxin substrate 1 (RAC1) in human cholesteatoma.
Lee NH; Chang JW; Choi J; Jung HH; Im GJ
Eur Arch Otorhinolaryngol; 2013 Feb; 270(2):455-9. PubMed ID: 22358380
[TBL] [Abstract][Full Text] [Related]
80. Expression of EGFR and Microvessel Density in Middle Ear Cholesteatoma.
Jin BJ; Min HJ; Jeong JH; Park CW; Lee SH
Clin Exp Otorhinolaryngol; 2011 Jun; 4(2):67-71. PubMed ID: 21716952
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
